Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Faulding's Kadian approved by FDA

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Cephalon reveals multicatalytic protease inhibitors

July 5, 1996

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Servier's prolyl endopeptidase inhibitor effective in amnesia model

July 5, 1996

Anseculin HCl enters phase II clinical trials

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Dolasetron equiefficent to granisetron in chemotherapy-induced emesis

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...